<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4250">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 14, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04775966</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL21_0067</org_study_id>
    <nct_id>NCT04775966</nct_id>
  </id_info>
  <brief_title>CPAP Observance During the COVID-19 (SARS-CoV-2) Pandemic</brief_title>
  <acronym>COVADENE</acronym>
  <official_title>CPAP Observance During the COVID-19 (SARS-CoV-2) Pandemic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of this work is that the COVID 19 pandemic and the associated lockdowns are&#xD;
      likely to modify the adherence to positive airway pressure (PAP) treatments among patients&#xD;
      with sleep apnea. Identifying these patients and identifying adherence &quot;trajectories&quot; over&#xD;
      time would help mobilize human and telemedicine resources on the patients most in need.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to compare PAP adherence during lockdowns in 2020 with&#xD;
      the corresponding weeks during 2019.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 15, 2021</start_date>
  <completion_date type="Actual">February 15, 2021</completion_date>
  <primary_completion_date type="Actual">February 15, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in positive airway pressure(PAP)-adherence during the first lockdown versus corresponding 2019 weeks (h/days)</measure>
    <time_frame>2020 versus 2019</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in positive airway pressure(PAP)-adherence during the second lockdown versus corresponding 2019 weeks (h/days)</measure>
    <time_frame>2020 versus 2019</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in PAP-adherence 2020 versus 2019 (h/days/weeks)</measure>
    <time_frame>2020 versus 2019</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the percentage of adherent patients (adherence &gt; 4h/day/week) during the first lockdown versus corresponding 2019 weeks (h/days)</measure>
    <time_frame>2020 versus 2019</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the percentage of adherent patients (adherence &gt; 4h/day/week) during the second lockdown versus corresponding 2019 weeks (h/days)</measure>
    <time_frame>2020 versus 2019</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in patient adherence 2020 versus 2019 (%).</measure>
    <time_frame>2020 versus 2019</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">8477</enrollment>
  <condition>Sleep Apnea Syndromes</condition>
  <arm_group>
    <arm_group_label>The study population</arm_group_label>
    <description>Patients meeting eligibility criteria (see appropriate section).</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients from the Adene group database treated with positive airway pressure (PAP) for&#xD;
        sleep apnea in 2019 and 2020.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient treated/monitored by the Adene group&#xD;
&#xD;
          -  treated for sleep apnea syndrome (i.e., an initial apnoea hypopnea index (iAHI) ≥ 30/h&#xD;
             or iAHI ≥ 15/h (and more than 10/h respiratory-effort-related arousal or&#xD;
             cardio-metabolic/respiratory comorbidities) associated with symptoms from among&#xD;
             sleepiness, tiredness, snoring, headaches, hypertension, reduced vigilance, libido&#xD;
             disorders, nocturia, choking or suffocation during sleep, daytime tiredness)&#xD;
&#xD;
          -  Positive airway pressure (PAP)-treated for at least 4 months before January 1, 2019&#xD;
&#xD;
          -  continuous PAP during 2019&#xD;
&#xD;
          -  continuous PAP during 2020&#xD;
&#xD;
          -  acceptance of PAP telemonitoring with consent given for data collection and data&#xD;
             anonymization&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  less than 360 daily PAP tele-monitored data per year for 2019&#xD;
&#xD;
          -  less than 360 daily PAP tele-monitored data per year for 2020&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dany Jaffuel, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>Montpellier University Hospitals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Adene Group</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 26, 2021</study_first_submitted>
  <study_first_submitted_qc>February 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2021</study_first_posted>
  <last_update_submitted>March 1, 2021</last_update_submitted>
  <last_update_submitted_qc>March 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sleep Apnea</keyword>
  <keyword>Positive Airway Pressure</keyword>
  <keyword>telemedicine</keyword>
  <keyword>COVID 19</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

